Selection of suitable delivery system is one of the crucial aspects in gene therapy that determines the efficiency of gene therapy. The past two decades have witnessed extensive efforts for finding ...
In recent years, we have seen rapid growth in the development of adeno-associated virus (AAV)-mediated gene therapy products that target fatal and highly debilitating diseases. Growth is evident in ...
The limiting factor in the development of local gene therapies for ISR is the lack of a safe and efficient vector system to transduce vascular cells within the arterial wall. 2 The optimal delivery ...